Correspondingly, treatment with anti-LINGO-1 antibody resulted in spinal cord remyelination and improved axonal integrity in MOG-induced experimental autoimmune encephalomyelitis [60] and lysolecithin-induced focal spinal cord demyelination in rats [61]. The gene discussed is LINGO1; the disease is experimental autoimmune encephalomyelitis.